Meeting
2024 ASCO Annual Meeting
Predicting completion of endocrine therapy for older patients with early-stage breast cancer.
Authors
Jerome Karp
NYU Langone Medical Center, New York, NY
Jerome Karp , Julie Xiao , Cheongeun Oh , Sylvia Adams , Nancy Chan , Freya Ruth Schnabel , Naamit Kurshan Gerber
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Adjuvant Therapy
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 535)
DOI
10.1200/JCO.2024.42.16_suppl.535
Abstract #
535
Poster Bd #
127
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
North American patterns of care in clinical stage I testicular cancer from SWOG S1823.
First Author: Antoine Morin Coulombe
Poster
2022 ASCO Quality Care Symposium
Bone health program: A community cancer center's experience.
First Author: Manasa Anipindi
Poster
2022 ASCO Annual Meeting
Estimating survival benefit of adjuvant chemotherapy in postmenopausal women with pT1-2N0 early-stage breast cancer and Oncotype DX recurrence score > 26: A National Cancer Database (NCDB) analysis.
First Author: Lifen Cao
Poster
2020 ASCO Virtual Scientific Program
Delayed adjuvant radiotherapy in early-stage cervical cancer with intermediate-risk features has a detrimental effect on survival that cannot be corrected by adjuvant chemotherapy.
First Author: Joyson Kodiyan